(GIVN) Givaudan - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0010645932
GIVN: Fragrances, Beauty, Flavours, Beverages, Snacks, Supplements
Givaudan SA is a Swiss-based global leader in the creation and manufacture of fragrances, flavors, and active beauty products. With a history dating back to 1796, the company has established itself as a cornerstone in the specialty chemicals sector, serving the consumer goods industry with a wide range of innovative solutions. Givaudan operates through two primary divisions: Fragrance & Beauty and Taste & Wellbeing, each catering to distinct but complementary markets.
The Fragrance & Beauty division is a powerhouse in the world of scents and personal care. It offers fine fragrances for luxury brands, as well as scent solutions for everyday consumer products like personal care items, home fragrances, fabric care, and oral hygiene. Additionally, it provides fragrance ingredients and active beauty products that are increasingly sought after in the growing skincare and cosmetics markets.
The Taste & Wellbeing division is equally expansive, focusing on flavor creation and functional ingredients for food, beverages, and nutraceuticals. It supplies flavors for beverages, including carbonated drinks, bottled water, and alcoholic beverages, as well as solutions for dairy products, snacks, and confectionery items. The division also delves into health-oriented products, offering supplements and nutraceuticals that align with the rising demand for wellness-focused consumption.
With operations spanning Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific, Givaudan has a truly global footprint. This geographic diversity not only strengthens its market reach but also positions it as a reliable partner for multinational consumer goods companies seeking consistent quality and innovation. Headquartered in Vernier, Switzerland, Givaudan continues to leverage its nearly 230 years of expertise to drive growth and innovation in the industries it serves.
From a financial perspective, Givaudan SA presents an attractive profile for investors. With a market capitalization of 36,360.65M CHF, the company is well-established and stable. Its price-to-earnings (P/E) ratio of 35.34 and forward P/E of 30.40 suggest that investors are betting on continued growth. The price-to-book (P/B) ratio of 8.36 indicates a premium valuation, reflecting the markets confidence in the companys intangible assets and brand strength. The price-to-sales (P/S) ratio of 4.99 further underscores its strong revenue generation capabilities. For fund managers and investors, Givaudan offers a unique blend of historical resilience, global reach, and future growth potential in the specialty chemicals and consumer goods sectors.
Additional Sources for GIVN Stock
GIVN Stock Overview
Market Cap in USD | 41,160m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
GIVN Stock Ratings
Growth 5y | 17.1% |
Fundamental | 73.4% |
Dividend | 60.7% |
Rel. Strength Industry | 5.91 |
Analysts | - |
Fair Price Momentum | 3833.21 CHF |
Fair Price DCF | 4941.38 CHF |
GIVN Dividends
Dividend Yield 12m | 3.40% |
Yield on Cost 5y | 5.24% |
Annual Growth 5y | 1.86% |
Payout Consistency | 97.3% |
GIVN Growth Ratios
Growth Correlation 3m | 17.3% |
Growth Correlation 12m | -23.5% |
Growth Correlation 5y | 15.9% |
CAGR 5y | 8.70% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 0.29 |
Alpha | 1.91 |
Beta | 0.23 |
Volatility | 21.32% |
Current Volume | 22.9k |
Average Volume 20d | 19.5k |
As of March 09, 2025, the stock is trading at CHF 4001.00 with a total of 22,878 shares traded.
Over the past week, the price has changed by -1.40%, over one month by +3.92%, over three months by +2.54% and over the past year by +5.37%.
Yes, based on ValueRay Fundamental Analyses, Givaudan (SW:GIVN) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 73.37 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GIVN as of March 2025 is 3833.21. This means that GIVN is currently overvalued and has a potential downside of -4.19%.
Givaudan has no consensus analysts rating.
According to ValueRays Forecast Model, GIVN Givaudan will be worth about 4173.2 in March 2026. The stock is currently trading at 4001.00. This means that the stock has a potential upside of +4.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 4165 | 4.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 4173.2 | 4.3% |